All articles by
Sanofi and Minapharm Sign an Exclusive Agreement for Localizing the manufacture of Clexane
This move towards localizing the manufacturing of Sanofi’s Clexane adapts to changing market dynamics and enhancement of industrial innovative technologies
Bayer, Salus Optima enter collaboration focused on healthy ageing
The current partnership follows Bayer’s recent alliance with UK-based diagnostic testing company Hurdle, focused on Hurdle’s saliva-based biological age test, which encourages Salus Optima’s digital application to define individual lifestyle goals
Bio-Thera Solutions gets US FDA approval for Avastin biosimilar Avzivi
The biosimilar is the second US FDA-approved medication for Bio-Thera and the second biosimilar researched, developed, and produced by a Chinese pharmaceutical company to get the FDA nod in the US
Danaher Completes Acquisition of Abcam
Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health
Osivax Receives Over USD 1.5M Grant from NIAID to Advance Development of Broad-Spectrum Influenza Vaccine Candidate, OVX836
OVX836 has already been evaluated in several Phase 2 clinical trials against seasonal influenza with initial signals of broad-spectrum protection
Aspen concludes two significant agreements with Sandoz for China and Europe
The Acquisition provides the opportunity to add approximately ZAR 1.8 billion of annual sales to the Aspen Group
Vanda Pharmaceuticals Announces that U.S. Food and Drug Administration Accepts New Drug Application for Tradipitant for the Treatment of Gastroparesis
If approved, tradipitant will be the first novel drug to be approved by the FDA for the treatment of gastroparesis in over 40 years and to be accepted for review by the FDA for gastroparesis in over 30 years
Everest Medicines Announces Investigational New Drug Application Acceptance of Zetomipzomib in China
Everest plans to contribute to the ongoing global Phase 2b PALIZADE trial of zetomipzomib in active lupus nephritis
Astellas and Seagen secure FDA priority review for Padcev, Keytruda combo in la/mUC
The sBLA is based on the results from the confirmatory EV-302 trial which found the combination therapy to significantly prolong overall survival and progression-free survival, compared to standard platinum containing chemotherapy
Teva Completes Closing of Exclusive Collaboration Deal to Deliver Inflammatory Bowel Disease Treatment
TEV ‘574 is currently in Phase 2b clinical trials for the treatment of ulcerative colitis and Crohn’s disease, two types of inflammatory bowel disease